Filing Flows › 8-K events › Select Water Solutions
Select Water Solutions: completion of an acquisition or disposition of assets
Form 8-K filed Nov 2, 2026 · items 1.02, 2.01, 2.03, 3.02, 7.01, 8.01
BuybacksSelect Water Solutions Announces Closing of Pilot Water Solutions Acquisition
What the filing says
As discussed in the Introductory Note, on the Closing Date, Select LLC completed the previously announced Pilot Water Acquisition. Pursuant to the Pilot Water Acquisition Agreement, Select LLC acquired all of the issued and outstanding membership interests in Pilot Water, a water midstream company with produced water d
Read the filing on SEC EDGAR →
What usually followsAcross 2,368 8-Ks reporting Item 1.02 (termination of a material agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.5%, up 51% of the time); over the following 21 sessions, +1.1%. Item 2.01: +0.1% next session across 2,671. Item 2.03: 0.0% next session across 13,268. Every item ranked →
What this kind of filing means
Item 1.02 — Termination of a material definitive agreement. Ending a material agreement can remove revenue, financing or a planned deal; the filing says who ended it and whether penalties apply.
Item 2.01 — Completion of an acquisition or disposition of assets. Completing an acquisition or a sale changes the company’s size and mix from this quarter on; the price paid and how it was financed are in the filing.
Item 2.03 — Creation of a direct financial obligation. New debt or a guarantee: the amount, the rate and the maturity set the cost of capital and the repayment wall ahead.
Select Water Solutions at a glance
Select Water Solutions, Q2 2026: revenue $396M (+9% year over year), operating margin 8.7%. The chart follows the revenue to costs, profit and cash.
Select Water Solutions: every quarter, Q/Q and Y/Y, holders and guidance →
Other recent buybacks
- Kontoor Brands Nov 6, 2026
- Align Technology Nov 6, 2026
- Concentra Group Holdings Parent Nov 5, 2026
- HF Sinclair Nov 5, 2026
- 1stdibs.com Nov 5, 2026
- Inogen Nov 5, 2026
- Diodes Nov 5, 2026
- ANI Pharmaceuticals Nov 5, 2026
- Teleflex Nov 5, 2026
- Adient Nov 4, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.